Mrinal Patnaik
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Mrinal Patnaik
Jun 27, 2024, 02:57 |
Blog
Mrinal Patnaik: ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact
Mrinal Patnaik, Physician Scientist with the Division of Hematology, Department of Internal Medicine at Mayo…
Apr 6, 2024, 11:46 |
Blog
Marissa Li: My very first full paper is published: The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance
Jan 1, 2024, 18:10 |
Blog
David Steensma: I learned how to talk to patients with leukemia largely from Mark
David Steensma, Chief Medical Officer at Ajax Therapeutics, shared a post by Mrinal Patnaik, physician…
Dec 26, 2023, 13:18 |
Insight
Sanam Loghavi: How we apply WHO in the Diagnosis and classification of myeloid neoplasms in practice
Sanam Loghavi shared a post on LinkedIn: ''On behalf of the WHO 5th Edition Classification…
All:
4
Posts:
1 - 10
We need to hurry up, because cancer and patients cannot wait!
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Facebook
RSS Feed
Twitter
Linkedin
Youtube